
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Osmetech | LSE:OMH | London | Ordinary Share | GB00B0K29R51 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.15 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMOMH RNS Number : 8530F Osmetech PLC 20 January 2010 20 January 2010 Osmetech PLC ('Osmetech' or 'the Company') Disclosure of Significant Shareholding On 1 December 2009, Osmetech posted a circular to its shareholders (the "Circular") regarding , inter alia, a proposed Placing. Contained within the Circular were certain disclosures regarding holdings in the Company of Dr Kayyem, a director of the Company. The Circular stated: "The exact number of Ordinary Shares that Dr Kayyem will beneficially own as a result of Efficacy's participation in the Placing cannot be completely determined until Efficacy has completed its own internal reporting and will be able to inform Dr Kayyem of his exact beneficial holding in the Company". Dr Kayyem has informed the Company that the internal reporting at Efficacy is now complete and Dr Kayyem has subsequently transferred out all of his beneficial holdings in Osmetech previously held with Efficacy. Dr Kayyem has confirmed he holds a beneficial holding in the Company totalling 116,355,087 Ordinary Shares, representing 7.12% of the current issued share capital of the Company, and none of which are now held through Efficacy. For the avoidance of doubt, Dr Kayyem has not bought or sold any Ordinary Shares in the Company since participating in the Placing as described in the Circular. As a result of Dr Kayyem transferring out his beneficial holdings in Osmetech from Efficacy, Efficacy now has a disclosable interest in the Company of 201,915,914 Ordinary Shares, representing 12.36% of the current issued share capital of the Company. The total number of issued Ordinary Shares is 1,633,443,351. Osmetech does not hold any Ordinary Shares in Treasury. Therefore, the total number of voting rights in Osmetech is 1,633,443,351. Unless otherwise sated, all defined terms in this announcement shall have the same meaning as those in the Circular of 01 December 2009. For further information: +----------------------+----------+ | Osmetech | +44 (0) | | plc: | 20 7849 | | | 6027 | +----------------------+----------+ | David | | | Sandilands, | | | Finance | | | Director | | +----------------------+----------+ | | | +----------------------+----------+ | | | +----------------------+----------+ | Canaccord | +44 (0) | | Adams | 20 7050 | | Limited: | 6500 | +----------------------+----------+ | Robert | | | Finlay | | +----------------------+----------+ | Henry | | | Fitzgerald-O'Connor | | +----------------------+----------+ This information is provided by RNS The company news service from the London Stock Exchange END HOLSEWFESFSSEFF
1 Year Osmetech Chart |
1 Month Osmetech Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions